Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages

Abstract

How the innate and adaptive host immune system miscommunicate to worsen COVID-19 immunopathology has not been fully elucidated. Here, we perform single-cell deep-immune profiling of bronchoalveolar lavage (BAL) samples from 5 patients with mild and 26 with critical COVID-19 in comparison to BALs from non-COVID-19 pneumonia and normal lung. We use pseudotime inference to build T-cell and monocyte-to-macrophage trajectories and model gene expression changes along them. In mild COVID-19, CD8 + resident-memory (T RM ) and CD4 + T-helper-17 (T H17 ) cells undergo active (presumably antigen-driven) expansion towards the end of the trajectory, and are characterized by good effector functions, while in critical COVID-19 they remain more naïve. Vice versa, CD4 + T-cells with T-helper-1 characteristics (T H1 -like) and CD8 + T-cells expressing exhaustion markers (T EX -like) are enriched halfway their trajectories in mild COVID-19, where they also exhibit good effector functions, while in critical COVID-19 they show evidence of inflammation-associated stress at the end of their trajectories. Monocyte-to-macrophage trajectories show that chronic hyperinflammatory monocytes are enriched in critical COVID-19, while alveolar macrophages, otherwise characterized by anti-inflammatory and antigen-presenting characteristics, are depleted. In critical COVID-19, monocytes contribute to an ATP-purinergic signaling-inflammasome footprint that could enable COVID-19 associated fibrosis and worsen disease-severity. Finally, viral RNA-tracking reveals infected lung epithelial cells, and a significant proportion of neutrophils and macrophages that are involved in viral clearance.

References 81

1. 1.

   World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Covid-19 Dashboard 1–1 (2020).

   Not in our library

2. 2.

   Fu L, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J. Infect. 2020;80:656-665.

   Not in our library10.1016/j.jinf.2020.03.041

3. 3.

   Chen G, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 2020;130:2620-2629.

   Not in our library10.1172/jci137244

4. 4.

   Liu K, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin. Med. J. (Engl). 2020;133:1025-1031.

   Not in our library10.1097/cm9.0000000000000744

5. 5.
   Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing · 2020

   Corrected
6. 6.

   Wilk AJ, et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 2020;26:1070-1076.

   Not in our library10.1038/s41591-020-0944-y

7. 7.
   Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity · 2021

   No notice
8. 8.

   Schulte-Schrepping J, et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell. 2020;182:1419-1440.

   Not in our library10.1016/j.cell.2020.08.001

9. 9.

   Silvin A, et al. Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell. 2020;182:1401-1418.

   Not in our library10.1016/j.cell.2020.08.002

10. 10.

    Zhang JY, et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat. Immunol. 2020;21:1107-1118.

    Not in our library10.1038/s41590-020-0762-x

11. 11.
    Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 · 2020

    No notice
12. 12.

    Cao Y, et al. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells. Cell. 2020;182:73-84.

    Not in our library10.1016/j.cell.2020.05.025

13. 13.
    Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals · 2020

    Corrected
14. 14.

    Liao M, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 2020;26:842-844.

    Not in our library10.1038/s41591-020-0901-9

15. 15.

    Bost P, et al. Host-viral infection maps reveal signatures of severe COVID-19 patients. Cell. 2020;181:1475-1488.

    Not in our library10.1016/j.cell.2020.05.006

16. 16.

    Chua RL, et al. COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis. Nat. Biotechnol. 2020;38:970-979.

    Not in our library10.1038/s41587-020-0602-4

17. 17.

    Lambrechts D, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat. Med. 2018;24:1277-1289.

    Not in our library10.1038/s41591-018-0096-5

18. 18.

    Reyfman PA, et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2019;9:1517-1536.

    Not in our library10.1164/rccm.201712-2410oc

19. 19.

    Qian J, et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res. 2020;30:745-762.

    Not in our library10.1038/s41422-020-0355-0

20. 20.

    Garg AD, Agostinis P. Cell death and immunity in cancer: from danger signals to mimicry of pathogen defense responses. Immunol. Rev. 2017;280:126-148.

    Not in our library10.1111/imr.12574

21. 21.

    Van Driel BJ, Liao G, Engel P, Terhorst C. Responses to microbial challenges by SLAMF receptors. Front. Immunol. 2016;7:1-14.

    Not in our library10.3389/fimmu.2016.00004

22. 22.

    Wherry EJ, et al. Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection. Immunity. 2007;27:670-684.

    Not in our library10.1016/j.immuni.2007.09.006

23. 23.

    Wang WH, et al. The role of galectins in virus infection - a systemic literature review. J. Microbiol. Immunol. Infect. 2019;53:925-935.

    Not in our library10.1016/j.jmii.2019.09.005

24. 24.

    Liu W, et al. Tim-4 in Health and Disease: friend or Foe? Front. Immunol. 2020;11:1-10.

    Not in our library10.3389/fimmu.2020.00001

25. 25.
    Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases · 2020

    No notice
26. 26.
    The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes · 2018

    Not checked
27. 27.

    Chechlinska M, et al. Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal. BMC Genom. 2009;10:261.

    Not in our library10.1186/1471-2164-10-261

28. 28.

    Miyazaki Y, Chen LC, Chu BW, Swigut T, Wandless TJ. Distinct transcriptional responses elicited by unfolded nuclear or cytoplasmic protein in mammalian cells. Elife. 2015;4:1-24.

    Not in our library10.7554/elife.07687

29. 29.
    The protective and pathogenic roles of IL-17 in viral infections: friend or foe? · 2019

    Not checked
30. 30.

    Cecchinato V, et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 2008;1:279-288.

    Not in our library10.1038/mi.2008.14

31. 31.

    Cohen M, et al. Lung Single-Cell Signaling Interaction Map Reveals Basophil Role in Macrophage Imprinting. Cell. 2018;175:1031-1044.

    Not in our library10.1016/j.cell.2018.09.009

32. 32.

    Liu H, Shi B, Huang CC, Eksarko P, Pope RM. Transcriptional diversity during monocyte to macrophage differentiation. Immunol. Lett. 2008;117:70-80.

    Not in our library10.1016/j.imlet.2007.12.012

33. 33.

    Willingham SB, et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc. Natl. Acad. Sci. USA. 2012;109:6662-6667.

    Not in our library10.1073/pnas.1121623109

34. 34.

    Garg AD, Romano E, Rufo N, Agostinis P. Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation. Cell Death Differ. 2016;23:938-951.

    Not in our library10.1038/cdd.2016.5

35. 35.

    Cauwels A, Rogge E, Vandendriessche B, Shiva S, Brouckaert P. Extracellular ATP drives systemic inflammation, tissue damage and mortality. Cell Death Dis. 2014;5:1-7.

    Not in our library10.1038/cddis.2014.70

36. 36.

    Krysko DV, et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol. 2011;32:157-164.

    Not in our library10.1016/j.it.2011.01.005

37. 37.

    Riteau N, et al. Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 2010;182:774-783.

    Not in our library10.1164/rccm.201003-0359oc

38. 38.

    Gavin C, et al. The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes. Front. Immunol. 2019;10:2249.

    Not in our library10.3389/fimmu.2019.02249

39. 39.

    Tippett E, Cameron PU, Marsh M, Crowe SM. Characterization of tetraspanins CD9, CD53, CD63, and CD81 in monocytes and macrophages in HIV-1infection. J. Leukoc. Biol. 2013;93:913-920.

    Not in our library10.1189/jlb.0812391

40. 40.

    Lévesque SA, Kukulski F, Enjyoji K, Robson SC, Sévigny J. NTPDase1 governs P2X7-dependent functions in murine macrophages. Eur. J. Immunol. 2010;40:1473-1485.

    Not in our library10.1002/eji.200939741

Cited by papers we hold 14

• Unveiling inflammatory and prehypertrophic cell populations as key contributors to knee cartilage degeneration in osteoarthritis using multi-omics data integration · 2024
  No notice
• An integrated cell atlas of the lung in health and disease · 2023
  No notice
• Alveolar macrophages in tissue homeostasis, inflammation, and infection: evolving concepts of therapeutic targeting · 2023
  No notice
• Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection · 2023
  No notice
• Myeloid cell interferon responses correlate with clearance of SARS-CoV-2 · 2022
  Not checked
• SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2 · 2022
  No notice
• Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis · 2022
  No notice
• A cohort autopsy study defines COVID-19 systemic pathogenesis · 2021
  No notice
• Neutrophils in COVID-19 · 2021
  No notice
• Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19 · 2021
  No notice
• Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity · 2021
  No notice
• Diversity of Macrophages in Lung Homeostasis and Diseases · 2021
  No notice
• Monocytes and Macrophages in COVID-19 · 2021
  No notice
• Necroptosis in Immuno-Oncology and Cancer Immunotherapy · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.